These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 23481498)

  • 1. Pharmacokinetics and pharmacodynamics of antimicrobial drugs in intensive care unit patients.
    Macedo RS; Onita JH; Wille MP; Furtado GH
    Shock; 2013 May; 39 Suppl 1():24-8. PubMed ID: 23481498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimicrobial pharmacokinetic and pharmacodynamic issues in the critically ill with severe sepsis and septic shock.
    Varghese JM; Roberts JA; Lipman J
    Crit Care Clin; 2011 Jan; 27(1):19-34. PubMed ID: 21144984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of pathophysiology on pharmacokinetics in the critically ill patient--concepts appraised by the example of antimicrobial agents.
    Blot SI; Pea F; Lipman J
    Adv Drug Deliv Rev; 2014 Nov; 77():3-11. PubMed ID: 25038549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How to optimise antimicrobial prescriptions in the Intensive Care Unit: principles of individualised dosing using pharmacokinetics and pharmacodynamics.
    Roberts JA; Joynt GM; Choi GY; Gomersall CD; Lipman J
    Int J Antimicrob Agents; 2012 Mar; 39(3):187-92. PubMed ID: 22226651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and pharmacodynamics: optimal antimicrobial therapy in the intensive care unit.
    Lodise TP; Drusano GL
    Crit Care Clin; 2011 Jan; 27(1):1-18. PubMed ID: 21144983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of acute kidney injury on antimicrobial dosing in critically ill patients: are dose reductions always necessary?
    Blot S; Lipman J; Roberts DM; Roberts JA
    Diagn Microbiol Infect Dis; 2014 May; 79(1):77-84. PubMed ID: 24602849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics/pharmacodynamics of antibacterials in the Intensive Care Unit: setting appropriate dosing regimens.
    Scaglione F; Paraboni L
    Int J Antimicrob Agents; 2008 Oct; 32(4):294-301. PubMed ID: 18621508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bench-to-bedside review: antimicrobial utilization strategies aimed at preventing the emergence of bacterial resistance in the intensive care unit.
    Kollef MH
    Crit Care; 2005 Oct; 9(5):459-64. PubMed ID: 16277734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. β-lactam pharmacokinetics and pharmacodynamics in critically ill patients and strategies for dose optimization: a structured review.
    Sinnollareddy MG; Roberts MS; Lipman J; Roberts JA
    Clin Exp Pharmacol Physiol; 2012 Jun; 39(6):489-96. PubMed ID: 22519600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic and pharmacodynamic issues for antimicrobial therapy in patients with cancer.
    Theuretzbacher U
    Clin Infect Dis; 2012 Jun; 54(12):1785-92. PubMed ID: 22437238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and antimicrobial dosing adjustment in critically ill patients during continuous renal replacement therapy.
    Kuang D; Verbine A; Ronco C
    Clin Nephrol; 2007 May; 67(5):267-84. PubMed ID: 17542336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma pharmacokinetics of antimicrobial agents in critically ill patients.
    Pea F
    Curr Clin Pharmacol; 2013 Feb; 8(1):5-12. PubMed ID: 22946868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimizing Pharmacokinetics-Pharmacodynamics of Antimicrobial Management in Patients with Sepsis: A Review.
    Phe K; Heil EL; Tam VH
    J Infect Dis; 2020 Jul; 222(Suppl 2):S132-S141. PubMed ID: 32691832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimicrobial therapy in critically ill patients: a review of pathophysiological conditions responsible for altered disposition and pharmacokinetic variability.
    Pea F; Viale P; Furlanut M
    Clin Pharmacokinet; 2005; 44(10):1009-34. PubMed ID: 16176116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimicrobial drug interactions in the critically ill patients.
    Pereira JM; Paiva JA
    Curr Clin Pharmacol; 2013 Feb; 8(1):25-38. PubMed ID: 22946870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antimicrobial therapy of severe infections in critically ill patients].
    Rybicki Z; Tomaszewski D
    Pol Merkur Lekarski; 2011 May; 30(179):338-41. PubMed ID: 21675137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic/pharmacodynamic modeling can help guide targeted antimicrobial therapy for nosocomial gram-negative infections in critically ill patients.
    Mohr JF; Wanger A; Rex JH
    Diagn Microbiol Infect Dis; 2004 Feb; 48(2):125-30. PubMed ID: 14972382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Some current issues in the pharmacokinetics/pharmacodynamics of antimicrobials in intensive care.
    Petrosillo N; Drapeau CM; Agrafiotis M; Falagas ME
    Minerva Anestesiol; 2010 Jul; 76(7):509-24. PubMed ID: 20613692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Continuing education: alternative approaches to optimizing antimicrobial pharmacodynamics in critically ill patients.
    Winterboer TM; Lecci KA; Olsen KM
    J Pharm Pract; 2010 Feb; 23(1):6-18. PubMed ID: 21507788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibacterial dosage in intensive-care-unit patients based on pharmacokinetic/pharmacodynamic principles.
    Soy D; Torres A
    Curr Opin Crit Care; 2006 Oct; 12(5):477-82. PubMed ID: 16943729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.